0
0
HYDERABAD, INDIA – Researchers at the Birla Institute of Technology and Science (BITS) Pilani, Hyderabad Campus, have developed a revolutionary miniaturized device capable of detecting dangerous bacteria, including the notorious Pseudomonas aeruginosa, in a mere 15 minutes. This innovation promises to significantly accelerate diagnostic processes in hospitals and clinics, potentially transforming infection control, particularly in resource-limited settings.
The development, detailed in a study published in the IEEE Open Journal of Engineering in Medicine and Biology, addresses the critical need for faster bacterial identification. Pseudomonas aeruginosa is a significant cause of severe infections, including pneumonia and complications in cystic fibrosis patients.
According to Professor Sanket Goel, Dean of Research & Innovation at BITS Pilani, Hyderabad Campus and co-lead researcher on the project, the device offers a powerful alternative to traditional methods. “This innovative technology can deliver results in just 15 minutes, promising to revolutionize bacterial infection diagnosis in hospitals and clinics,” stated Professor Goel.
He emphasized the device’s key advantages: its compact size, affordability, and suitability for rapid, on-site testing. “Unlike existing bacterial detection methods, which are often slow and reliant on sophisticated laboratory equipment, this device is designed for rapid on-site testing, particularly in resource-constrained environments,” Professor Goel explained.
The technology hinges on Recombinase Polymerase Amplification (RPA), a technique that effectively amplifies bacterial DNA at lower, constant temperatures. This eliminates the need for expensive thermal cycling equipment commonly required for other DNA amplification methods like PCR. The device also integrates a photometric detection system sensitive enough to identify even trace amounts of the target bacterial DNA.
Researchers highlighted the platform’s versatility, noting its potential for easy adaptation to detect other types of harmful bacteria beyond Pseudomonas aeruginosa. This breakthrough holds significant potential to enhance healthcare diagnostics globally by enabling quicker pathogen identification, leading to more timely treatment and ultimately improving patient outcomes.
Disclaimer: This news article is based on information sourced from an article published by The Hindu on October 17, 2024, regarding research conducted at BITS Pilani, Hyderabad Campus, detailed in the IEEE Open Journal of Engineering in Medicine and Biology. While efforts have been made to accurately represent the source material, this article is a summary and may not encompass all details of the original research or report.
